Cargando…

GPER1 and microRNA: Two Players in Breast Cancer Progression

Breast cancer is the main cause of morbidity and mortality in women worldwide. However, the molecular pathogenesis of breast cancer remains poorly defined due to its heterogeneity. Several studies have reported that G Protein-Coupled Estrogen Receptor 1 (GPER1) plays a crucial role in breast cancer...

Descripción completa

Detalles Bibliográficos
Autor principal:	Vivacqua, Adele
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7795792/ https://www.ncbi.nlm.nih.gov/pubmed/33374170 http://dx.doi.org/10.3390/ijms22010098

Ejemplares similares

GPER is involved in the regulation of the estrogen-metabolizing CYP1B1 enzyme in breast cancer
por: Cirillo, Francesca, et al.
Publicado: (2017)

SIRT1 is involved in oncogenic signaling mediated by GPER in breast cancer
por: Santolla, M F, et al.
Publicado: (2015)

GPER Mediates a Feedforward FGF2/FGFR1 Paracrine Activation Coupling CAFs to Cancer Cells toward Breast Tumor Progression
por: Santolla, Maria Francesca, et al.
Publicado: (2019)

Differential MicroRNA Landscape Triggered by Estrogens in Cancer Associated Fibroblasts (CAFs) of Primary and Metastatic Breast Tumors
por: Vivacqua, Adele, et al.
Publicado: (2019)

GPER signalling in both cancer-associated fibroblasts and breast cancer cells mediates a feedforward IL1β/IL1R1 response
por: De Marco, Paola, et al.
Publicado: (2016)

Focal adhesion kinase (FAK) activation by estrogens involves GPER in triple-negative breast cancer cells
por: Rigiracciolo, Damiano Cosimo, et al.
Publicado: (2019)

Estrogenic gper signaling regulates mir144 expression in cancer cells and cancer-associated fibroblasts (cafs)
por: Vivacqua, Adele, et al.
Publicado: (2015)

miR-338-3p Is Regulated by Estrogens through GPER in Breast Cancer Cells and Cancer-Associated Fibroblasts (CAFs)
por: Vivacqua, Adele, et al.
Publicado: (2018)

Association between GPER gene polymorphisms and GPER expression levels with cancer predisposition and progression
por: Ulhaq, Zulvikar Syambani, et al.
Publicado: (2021)

GPER Function in Breast Cancer: An Overview
por: Lappano, Rosamaria, et al.
Publicado: (2014)

Crosstalk between Notch, HIF-1α and GPER in Breast Cancer EMT
por: De Francesco, Ernestina M., et al.
Publicado: (2018)

MicroRNA-183 in Cancer Progression
por: Cao, Dingren, et al.
Publicado: (2020)

MicroRNA-126: A new and promising player in lung cancer
por: Chen, Qijun, et al.
Publicado: (2021)

MicroRNA: Important Player in the Pathobiology of Multiple Myeloma
por: Bi, Chonglei, et al.
Publicado: (2014)

Stimulatory actions of IGF-I are mediated by IGF-IR cross-talk with GPER and DDR1 in mesothelioma and lung cancer cells
por: Avino, Silvia, et al.
Publicado: (2016)

NHERF1, a novel GPER associated protein, increases stability and activation of GPER in ER-positive breast cancer
por: Meng, Ran, et al.
Publicado: (2016)

Role of GPER-Mediated Signaling in Testicular Functions and Tumorigenesis
por: Chimento, Adele, et al.
Publicado: (2020)

The MicroRNA-148/152 Family: Multi-faceted Players
por: Chen, Yue, et al.
Publicado: (2013)

MicroRNA‑378: An important player in cardiovascular diseases (Review)
por: Wang, Huan, et al.
Publicado: (2023)

GPER Signaling in Spermatogenesis and Testicular Tumors
por: Chimento, Adele, et al.
Publicado: (2014)

MicroRNAs as New Players for Diagnosis, Prognosis, and Therapeutic Targets in Breast Cancer
por: Ng, Enders K. O., et al.
Publicado: (2009)

27-Hydroxycholesterol Binds GPER and Induces Progression of Estrogen Receptor-Negative Breast Cancer
por: Avena, Paola, et al.
Publicado: (2022)

Toll like receptor signaling in “inflammaging”: microRNA as new players
por: Olivieri, Fabiola, et al.
Publicado: (2013)

MicroRNAs and Androgen Receptor: Emerging Players in Breast Cancer
por: Bandini, Erika, et al.
Publicado: (2019)

MicroRNA Regulation of Breast Cancer Stemness
por: Humphries, Brock, et al.
Publicado: (2021)

Role of MicroRNA-30c in cancer progression
por: Han, Wenyan, et al.
Publicado: (2020)

MicroRNA-490 inhibits tumorigenesis and progression in breast cancer
por: Zhao, Lin, et al.
Publicado: (2016)

Autocrine motility factor promotes endometrial cancer progression by targeting GPER-1
por: Li, Yiran, et al.
Publicado: (2019)

MicroRNAs: Novel Players in Cancer Diagnosis and Therapies
por: Oom, Aaron L., et al.
Publicado: (2014)

MicroRNA-384 inhibits the progression of breast cancer by targeting ACVR1
por: Wang, Yongxia, et al.
Publicado: (2018)

Micro-Players of Great Significance—Host microRNA Signature in Viral Infections in Humans and Animals
por: Ostrycharz, Ewa, et al.
Publicado: (2022)

MicroRNAs: short non-coding players in cancer chemoresistance
por: Donzelli, Sara, et al.
Publicado: (2014)

Are microRNAs Important Players in HIV-1 Infection? An Update
por: Balasubramaniam, Muthukumar, et al.
Publicado: (2018)

MicroRNA dysregulation in uveal melanoma: a new player enters the game
por: Li, Zheng, et al.
Publicado: (2015)

MicroRNA: A Dynamic Player from Signalling to Abiotic Tolerance in Plants
por: Ma, Ziming, et al.
Publicado: (2023)

MicroRNAs: emerging players in apical periodontitis
por: SHEN, Zhen, et al.
Publicado: (2021)

MicroRNA-mediated drug resistance in breast cancer
por: Kutanzi, Kristy R., et al.
Publicado: (2011)

MicroRNA Regulation of Epigenetic Modifiers in Breast Cancer
por: Humphries, Brock, et al.
Publicado: (2019)

MicroRNA Expression Profiles and Breast Cancer Chemotherapy
por: Davey, Matthew G., et al.
Publicado: (2021)

MicroRNAs: Important Players in Breast Cancer Angiogenesis and Therapeutic Targets
por: Hussen, Bashdar Mahmud, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_2ms7dsbocku1e0qburqlpdj41t